The upregulation of HK2 in cancer is a major contributor to the elevated aerobic glycolysis and “Warburg effect” in cancer, and the low expression of HK2 in specific normal tissues makes it an attractive target for the selective inhibition of glucose metabolism in cancer (5, 8, 15, 17, 18). This evidence concerns the gene HK2 and cancer.